Cargando…
A case of long QT syndrome type 2 that developed torsades de pointes two days after the initiation of oral β-blocker therapy
Autores principales: | Yoneda, Fumiya, Makiyama, Takeru, Miyahara, Kosuke, Fukuoka, Yoshitomo, Aiba, Takeshi, Kimura, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811028/ https://www.ncbi.nlm.nih.gov/pubmed/36618596 http://dx.doi.org/10.1016/j.hrcr.2022.08.003 |
Ejemplares similares
-
DOTHIEPIN, QT PROLONGATION AND TORSADES DE POINTES
por: Andrade, Chittaranjan, et al.
Publicado: (1999) -
QT prolongation and torsades de pointes with psychotropic agents
por: Desai, Nagaraj, et al.
Publicado: (2015) -
QT Dispersion and Drug-Induced Torsade de Pointes
por: Friedman, Ari, et al.
Publicado: (2021) -
Acquired Long QT Syndrome and Electrophysiology of Torsade de Pointes
por: El-Sherif, Nabil, et al.
Publicado: (2019) -
Landiolol suppression of electrical storm of torsades de pointes in patients with congenital long-QT syndrome type 2 and myocardial ischemia
por: Kitajima, Ryota, et al.
Publicado: (2017)